Novalis Circle Hosts Symposium on Latest Neurosurgical Developments in the Treatment of High-Grade Gliomas
Defining new treatment opportunities for patients with recurring diseaseScottsdale, AZ, Friday, November 18, 2016 — The Novalis Circle, a worldwide network of clinicians dedicated to the advancement of radiosurgery, today announced an advanced symposium to be held during the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology at the Scottsdale Fairmont Princess Hotel, November 17 — 20, 2016.
The Novalis Circle panel of member-experts will present new tools for identifying patient response to treatment and the need for therapy shifts in the treatment of high-grade gliomas. The panel will also present exploratory solutions to integrate immunotherapy or intracerebral targeted-agent therapy.
«Novalis Circle promotes the exchange of educational and scientific advancements in radiosurgery and stereotactic body radiation therapy,» stated Sean Clark, President, Brainlab, Inc. «Technologies and economics are constantly changing the landscape of medicine. In partnership with Novalis member-experts, Brainlab will further promote clinical best practices and improved outcomes.»
Renowned neuro-oncology experts will be discussing advancements in the treatment of high-grade gliomas:
Orin Bloch, MD, Northwestern Memorial Hospital will address the clinical benefit of vaccines derived from recurrent disease aimed at triggering an immune response. Mid-point data evaluation of his Phase II/III trial will be reviewed together with the value-add of neuronavigation, mapping and intraoperative structure update in the re-operative context.
Andrew Brenner, MD, University of Texas, San Antonio will discuss the value of targeted agents and present his Phase I/II results. Dr. Brenner utilizes technology to plan and deliver the treatment agent directly to the brain to bypass the blood brain barrier. Discussions around this convection-enhanced drug delivery will include trajectory planning / selection and drug flow planning.
Yael Mardor, PhD, Sheeba Medical Center will provide a review on glioma treatment response assessment using delayed contrast extravasion MRI. Dr. Mardor’s work is especially relevant considering the multi-disciplinary treatment paradigm for high-grade gliomas and of paramount interest for the neuro-oncological community.
The Novalis Circle Symposium will take place in the Dorado Room of the Fairmont Princess Hotel on Friday, November 18, from 5:30-7:30 PM. To register, visit the Novalis Circle website.
The information given in these presentations solely reflects the opinion of the presenter and was not prepared by Brainlab.
About Novalis Circle
Novalis Circle is a worldwide network of clinicians dedicated to the advancement of radiosurgery. Novalis® Radiosurgery users represent the leading edge in the application of Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) and their participation in the Novalis Circle community indicates their strong commitment to improving healthcare. Novalis Circle provides a communication and collaboration network for developing new ideas and optimizing treatments that will continue to change the face of cancer treatment.
About Novalis Radiosurgery
Novalis® Radiosurgery is an advanced configuration of specialized tools dedicated to fast, precise and highly targeted SRS and SBRT treatments. Available at more than 450 centers worldwide, the Novalis Radiosurgery Program is built on over two decades of stereotactic expertise with cutting edge software and equipment developed specifically for radiosurgery.